Browsing Tag
Prostate cancer
33 posts
Telix Pharmaceuticals gains U.S. Medicare reimbursement code for Gozellix prostate cancer imaging agent
Telix Pharmaceuticals’ Gozellix secures U.S. reimbursement code, opening access to PSMA-PET prostate cancer imaging. Find out what’s next for its rollout and impact.
Johnson & Johnson seeks EMA approval to expand AKEEGA use for HRR-altered prostate cancer patients
Johnson & Johnson files for EMA approval to extend AKEEGA use in high-risk prostate cancer. Find out how this combo may redefine standard of care.
Clarity Pharmaceuticals bags FDA fast track designation for prostate cancer candidate 67Cu-SAR-bisPSMA
Clarity Pharmaceuticals has achieved a major regulatory milestone with the United States Food and Drug Administration (FDA) granting…
Prostate cancer diagnosis: A breakthrough in non-invasive testing
Prostate cancer is one of the most prevalent cancers affecting men globally, ranking sixth in occurrence after cancers…
Biomerica’s Fortel PSA Test gains approval for prostate cancer detection in UAE
The United Arab Emirates Ministry of Health and Prevention (MOHAP) has granted regulatory approval for the Fortel Prostate…
Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its…
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval…
Merck secures exclusive global license for opevesostat from Orion Corporation
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has enhanced its strategic position…
Telix Pharmaceuticals advances prostate cancer treatment with successful TLX592 study
Telix Pharmaceuticals Limited (ASX: TLX) has announced the successful completion of the CUPID Phase I dose escalation study…
AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals…